What You Should Know:
– FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a collaboration on a prospective research study with investigators at Brigham and Women’s Hospital in Boston.
– The research will assess the impact of FeelBetter’s AI-based Precision Population Health Platform on polypharmacy patient management.
Revolutionizing Polypharmacy Management: FeelBetter’s Innovative Approach
Launched in February 2024, this collaborative study will prospectively monitor patients under care at the hospital’s Phyllis Jen Center for Primary Care, assessing FeelBetter’s potential to enhance health outcomes while reducing healthcare utilization and costs. Building upon retrospective research from Brigham and Women’s Hospital in 2022, which demonstrated FeelBetter’s ability to predict medication-related adverse events among senior patients and suggest necessary changes to their medication routines, this new investigation aims to further validate its effectiveness.
Presented at the Society of General Internal Medicine (SGIM) 2023 Annual Meeting and the 2023 Annual Research Meeting (ARM) of AcademyHealth, the previous research indicated FeelBetter’s capability to stratify the risk of emergency department visits and hospitalizations among patients with complex medication regimes and multiple chronic conditions. Moreover, when coupled with medication management interventions, FeelBetter exhibited potential in reducing healthcare expenses and improving patient outcomes.
As part of the pilot program, FeelBetter will integrate its platform with Epic’s EHR system, streamlining workflows and enabling automated processes. Powered by Pharmaco-Clinical Intelligence, a groundbreaking fusion of AI-based analyses and evidence-based pharmacology and clinical capabilities, FeelBetter identifies high-risk patients for near-term hospitalization due to polypharmacy issues. By recommending changes to medication regimens and other necessary clinical interventions while monitoring progress comprehensively, FeelBetter transforms the approach to polypharmacy management at both individual and population health levels.
FeelBetter pioneers Pharmaco-Clinical Intelligence, revolutionizing polypharmacy management through a comprehensive solution designed to address the challenges of suboptimal medication management. Leveraging AI and machine learning, FeelBetter’s technology empowers healthcare professionals to ensure the safety, efficacy, and appropriateness of their patients’ medication regimens.
“Many polypharmacy problems aren’t detected until patients end up in the ER and, in seniors with several chronic diseases and conditions, the simultaneous use of multiple medications ultimately contributes to 10-30% of hospitalizations,” said Lisa Rotenstein, MD MBA MSc, the principal investigator of the study. “Our previous study showed that its platform can be used to identify which patients are at the highest risk of polypharmacy-related adverse events. Based on retrospective data, we’re excited to prospectively examine how the platform can potentially be used to improve patient outcomes, healthcare utilization, and cost efficiencies.”
